French Prospective Cohort of Innovative Endoscopic Interventions in Expert Centers
CoPPInE
1 other identifier
observational
10,000
1 country
2
Brief Summary
The creation of a multi-center French cohort pooling data from innovative endoscopies carried out in France every year would make it possible to produce excellent scientific results and analyze on a large scale the results of our current practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2034
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2034
September 19, 2024
September 1, 2024
9.9 years
September 6, 2024
September 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the effectiveness of diagnostic, therapeutic and/or innovative endoscopic practiced in French expert centers over the next 10 years.
10 years
Secondary Outcomes (5)
Evaluate the safety of diagnostic and therapeutic and/or innovative endoscopic techniques performed in French expert centers over the next 10 years.
10 years
Evaluate the secondary failure rate
10 years
Evaluate operating time
10 years
Evaluate inter-operator variability in efficacy
10 years
Evaluate long-term efficacy
10 years
Interventions
Evaluate the effectiveness of diagnostic and therapeutic and/or innovative endoscopic techniques practiced in French expert centers over the next 10 years with the rate of technical success (procedure completed) and clinical success (cure) of the digestive pathology presented by the patient who indicated endoscopy without recourse to a new intervention (endoscopic or surgical) within 30 days of the procedure.
Eligibility Criteria
All patients undergoing innovative diagnostic or therapeutic endoscopy who do not express opposition to the use of their data from examination reports. The aim of the cohort is to provide follow-up data on innovative procedures in digestive endoscopy, in order to justify their value. Patients included in the CoPPInE innovative digestive endoscopy cohort will be considered as undergoing innovative endoscopy
You may qualify if:
- Patients \> 18 yo
- Patient able to give consent
- Patient with innovative endoscopy
You may not qualify if:
- Opposition to participation in the present project to be notified in the file
- Patient under court protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Chu Nimes
Nîmes, 30900, France
Hôpital Européen Georges Pompidou AP-HP
Paris, 75015, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2024
First Posted
September 19, 2024
Study Start
October 1, 2024
Primary Completion (Estimated)
September 1, 2034
Study Completion (Estimated)
September 1, 2034
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share